Detalhe da pesquisa
1.
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults.
Eur Respir J
; 63(3)2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485149
2.
Patient-reported treatment response in chronic graft-versus-host disease.
Haematologica
; 109(1): 143-150, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37226713
3.
Associations of Germline Genetic Variants With Depression and Fatigue Among Hematologic Cancer Patients Treated With Allogeneic Hematopoietic Cell Transplantation.
Psychosom Med
; 85(9): 813-819, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37678326
4.
Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease.
Haematologica
; 108(2): 483-489, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615925
5.
Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair.
Am J Transplant
; 22(3): 717-730, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668635
6.
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Blood
; 135(2): 97-107, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738834
7.
Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease - a real-world outcomes analysis.
Br J Haematol
; 195(3): 429-432, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34254289
8.
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR.
Blood
; 134(12): 924-934, 2019 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31292117
9.
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.
Proc Natl Acad Sci U S A
; 115(7): 1582-1587, 2018 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29382747
10.
Ixazomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Phase II Trial.
Biol Blood Marrow Transplant
; 26(9): 1612-1619, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32464285
11.
Carfilzomib for Treatment of Refractory Chronic Graft-versus-Host Disease: A Chronic GVHD Consortium Pilot Phase II Trial.
Biol Blood Marrow Transplant
; 26(2): 278-284, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31499215
12.
Sole Upfront Therapy with Beclomethasone and Budesonide for Upper Gastrointestinal Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(7): 1303-1311, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32361010
13.
Disability Related to Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 26(4): 772-777, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669175
14.
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(8): 1459-1468, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434056
15.
Progress in risk-adapted acute GVHD therapy.
Blood
; 141(5): 443-444, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36729547
16.
A mindfulness-based intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: Pilot results.
Psychooncology
; 29(5): 934-937, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043667
17.
Proinflammatory Cytokine and Adipokine Levels in Adult Unrelated Marrow Donors Are Not Associated with Hematopoietic Cell Transplantation Outcomes.
Biol Blood Marrow Transplant
; 25(1): 12-18, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144561
18.
The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(2): 279-286, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30219700
19.
Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(9): 1869-1874, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085305
20.
Urgent Time to Allogeneic Hematopoietic Cell Transplantation: A National Survey of Transplant Physicians and Unrelated Donor Search Coordinators Facilitated by the Histocompatibility Advisory Group to the National Marrow Donor Program.
Biol Blood Marrow Transplant
; 25(12): 2501-2506, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31419569